wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34016480-4CE62C40-6CFB-4DF9-894D-0B5FD15FF488
Q34016480-4CE62C40-6CFB-4DF9-894D-0B5FD15FF488
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34016480-4CE62C40-6CFB-4DF9-894D-0B5FD15FF488
Current Approaches and Emerging Directions in HER2-resistant Breast Cancer.
P2860
Q34016480-4CE62C40-6CFB-4DF9-894D-0B5FD15FF488
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34016480-4CE62C40-6CFB-4DF9-894D-0B5FD15FF488
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
127fe2f947a4b1108b5ff8cf3d8118d76f31fce1
P2860
Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trial